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Leucine-rich repeat transmembrane proteins
(LRRTMs) are synaptic cell adhesion molecules that
trigger excitatory synapse assembly in cultured
neurons and influence synaptic function in vivo, but
their role in synaptic plasticity is unknown. shRNA-
mediated knockdown (KD) of LRRTM1 and LRRTM2
in vivo in CA1 pyramidal neurons of newborn
mice blocked long-term potentiation (LTP) in acute
hippocampal slices. Molecular replacement experi-
ments revealed that the LRRTM2 extracellular
domain is sufficient for LTP, probably because it
mediates binding to neurexins (Nrxs). Examination
of surface expression of endogenous AMPA recep-
tors (AMPARs) in cultured neurons suggests that
LRRTMs maintain newly delivered AMPARs at syn-
apses after LTP induction. LRRTMs are also required
for LTP of mature synapses on adult CA1 pyramidal
neurons, indicating that the block of LTP in neonatal
synapses by LRRTM1 and LRRTM2 KD is not due
to impairment of synapse maturation.
INTRODUCTION
Neurons use complex mechanisms that allow activity patterns
to regulate the complement of AMPA receptors (AMPARs) at
synapses. Long-term potentiation (LTP) at excitatory synapses
on hippocampal CA1 pyramidal cells remains the most compel-
ling and extensively studied model of such synaptic plasticity
(Bliss and Collingridge, 1993; Malenka and Bear, 2004). Despite
decades of mechanistic work on this phenomenon and the
general consensus that it involves an increase in the number of
synaptic AMPARs (Bredt and Nicoll, 2003; Collingridge et al.,
2004; Malinow and Malenka, 2002; Shepherd and Huganir,
2007), the mechanisms underlying the trafficking of AMPARs
to the synapse and their stabilization within the postsynaptic
density (PSD) during LTP remain controversial and poorly
understood.LTPmay involve several mechanistically distinct steps: exocy-
tosis of AMPARs into the plasma membrane at peri- or extrasy-
naptic sites, lateral diffusion of perisynaptic AMPARs into the
PSD, and direct or indirect trapping of these AMPARs within
the PSD (Henley et al., 2011; Kennedy and Ehlers, 2006; Opazo
and Choquet, 2011; Opazo et al., 2012). Although manipulations
of membrane-associated guanylate kinases (MAGUKs) such
as PSD95, which are prevalent proteins in the PSD, have effects
on basal excitatory synaptic transmission (Elias and Nicoll,
2007), their necessity in mediating the increase in synaptic
strength during LTP is unclear. Functional redundancy among
the MAGUKs may explain the finding that removal or reduction
of individual MAGUKs does not significantly impair LTP (Carlisle
et al., 2008; Cuthbert et al., 2007; Ehrlich et al., 2007; Howard
et al., 2010; Migaud et al., 1998). However, other hypotheses
are equally plausible. Notably, recent findings suggest that
the mechanisms controlling the delivery and maintenance of
synaptic AMPARs in basal conditions and during LTP may be
distinct (Adesnik et al., 2005; Ahmad et al., 2012; Jurado et al.,
2013; Sumioka et al., 2011).
Synaptic cell adhesion proteins are involved in the formation,
maturation, and specification of synapses (Dalva et al., 2007;
Missler et al., 2012; Siddiqui and Craig, 2011). Neuroligins
(NLs) have attracted particular attention because of their synap-
togenic actions when overexpressed and their genetic asso-
ciation with neuropsychiatric disorders (Craig and Kang, 2007;
Krueger et al., 2012; Su¨dhof, 2008). Although knockdown (KD)
or knockout (KO) of NL1 can impair LTP, this effect may be
due to the associated reduction of NMDA receptor (NMDAR)-
mediated currents and spine calcium influx (Blundell et al.,
2010; Chubykin et al., 2007; Kim et al., 2008; Kwon et al.,
2012). Recently, KD of NL1 has been reported to impair LTP
in dentate gyrus granule cells and neonatal CA1 pyramidal cells
independent of an effect on NMDARs, but not at synapses on
mature CA1 pyramidal cells, possibly because the LTP deficit
due to NL1 KD occurs only at recently formed, immature synap-
ses (Shipman and Nicoll, 2012).
Like NLs, LRRTMs are synaptogenic in vitro, potently bind
to presynaptic Nrxs, and are associated with neuropsychiatric
disorders (de Wit et al., 2009, 2011; Francks et al., 2007;
Ko et al., 2009; Linhoff et al., 2009; Siddiqui et al., 2010; SousaNeuron 79, 439–446, August 7, 2013 ª2013 Elsevier Inc. 439
Figure 1. In Vivo LRRTM1 and LRRTM2 Double Knockdown in Neonatal CA1 Pyramidal Neurons Blocks LTP
(A) Schematic of shRNA and replacement lentiviral backbone and the experimental approach for LTP experiments in young mice. (B) Low-magnification images
of an acute hippocampal slice in DIC (left) and epifluorescence (right) modes showing specific CA1 infection. (C) High-magnification (603) images of the boxed
region in (B) showing mosaic GFP expression and a patched CA1 pyramidal neuron. (D) Time courses of representative LTP experiments for control (left) and
double knockdown (DKD) neurons (right). Averages of 30 consecutive EPSCs during the baseline (1) and 46–50min after tetanic stimulation (2, delivered at time 0)
are shown above each graph. (E) Summary time course (left), cumulative fraction of all experiments in the set (middle), and quantification of the LTP magnitude
(right) for DKD cells and interleaved controls. In this and all subsequent figures, summary data are presented as mean ± SEM and numbers in parentheses
represent number of cells. *p < 0.01. (F and G) As in (D) and (E) for LTD experiments.
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LRRTMs Are Essential for LTPet al., 2010). However, the functional role of LRRTMs at synapses
is just beginning to be explored. LRRTMs comprise a family of
four (LRRTM1–LRRTM4) homologous, type I transmembrane
proteins with differential distribution within the brain (Laure´n
et al., 2003). While the KD of LRRTM1 and/or LRRTM2 in vitro
does not cause a change in synapse numbers (Ko et al., 2011),
and LRRTM KDs in vitro and in vivo have yielded somewhat
inconsistent results, decreases in AMPAR surface expression
in vitro and AMPAR-mediated synaptic transmission in vivo
have been observed (de Wit et al., 2009; Soler-Llavina et al.,
2011). Furthermore, LRRTMs may directly bind to AMPAR
subunits both in vitro and in vivo (de Wit et al., 2009; Schwenk
et al., 2012).
Here we used in vivo, viral-mediated KD of LRRTM1 and
LRRTM2 (double knockdown, DKD) to examine the role of
LRRTMs in LTP at excitatory synapses on CA1 pyramidal
neurons in mouse hippocampus. LRRTM DKD blocked or dra-
matically impaired LTP in neonatal (postnatal days 14–18 [P14–
P18]) and mature (P35–P39) CA1 pyramidal neurons, respec-
tively. Molecular replacements with recombinant LRRTM2
revealed that its extracellular LRR domain, probably via interac-
tions with Nrxs, is critical for LRRTM function in LTP. Assays
of AMPAR surface expression in cultured hippocampal neurons
suggest that LRRTMs are required for the stabilization of
AMPARs at synapses after LTP induction. These results reveal
an unexpected role for LRRTMs in LTP at both young andmature
synapses and are consistent with a model in which LRRTMs440 Neuron 79, 439–446, August 7, 2013 ª2013 Elsevier Inc.are required for maintaining or trapping AMPARs at synapses
during the initial phase of LTP.
RESULTS
In Vivo DKD of LRRTM1 and LRRTM2 Blocks LTP
To explore the role of LRRTMs in NMDAR-dependent LTP, we
used well-characterized shRNAs that in dissociated cultured
neurons suppress endogenous mRNAs for LRRTM1 and
LRRTM2, the two isoforms highly expressed in CA1 (Laure´n
et al., 2003), by 90% and 75%, respectively (Ko et al.,
2011; Soler-Llavina et al., 2011). A lentivirus expressing
the shRNAs and GFP was injected into the hippocampus of
P0 wild-type mice (Figure 1A). Acute slices were prepared 14–
18 days postinfection and whole-cell recordings from CA1 pyra-
midal neurons were made (Figures 1B and 1C). While control
neurons in slices prepared from infected animals exhibited
robust LTP (Figures 1D and 1E; 1.62 ± 0.23 of baseline 46–
50 min after induction, n = 8), LTP was blocked in DKD neurons
expressing the LRRTM1 and LRRTM2 shRNAs (Figures 1D and
1E; 0.99 ± 0.1, n = 19). Similar to other manipulations that block
LTP (Malenka and Nicoll, 1993), DKD neurons exhibited an initial
potentiation that returned to baseline over 40–50 min. To deter-
mine whether LRRTM1 and LRRTM2 have a specific role in LTP,
we assessed the effect of the DKD on NMDAR-dependent
long-term depression (LTD). LTD in DKD and uninfected control
neurons was identical (Figures 1F and 1G; control = 0.49 ± 0.06,
Figure 2. The Extracellular Domain of LRRTM2 Is Sufficient for Its Function in LTP
(A, C, E, and G) Diagrams of the lentiviral vector and recombinant LRRTM2 constructs used for molecular replacement and overexpression experiments (top left).
Sample, average EPSCs during baseline and after LTP expression (bottom left) and time course (right) of representative, single LTP experiments after the
indicated molecular manipulations. (B, D, F, and H) Summary time course (left), cumulative fraction of all experiments in the set (middle), and quantification of the
LTPmagnitude (right) for molecularly manipulated and corresponding interleaved control neurons. The DKD-LRR2 (A) and DKD-LRR2Ex (E) sets were performed
in parallel and therefore share the same control group. For clarity, and to facilitate visual comparison, this control group was plotted in both (B) and (F). *p < 0.01.
Summary data are presented as mean ± SEM. (See also Figures S1–S3.)
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LRRTMs Are Essential for LTPn = 9; DKD = 0.48 ± 0.04, n = 10), a result that is consistent with
the lack of an effect of the DKD on NMDAR-mediated synaptic
responses (Soler-Llavina et al., 2011). These results suggest
that LRRTMs have a critical, requisite role in LTP and that the
block of LTP by DKD is not due to an impairment in the induction
of LTP.
To test whether the block of LTP by LRRTMDKDmight be due
to off-target effects of the shRNAs, we performed experiments
in which we replaced LRRTM1 and LRRTM2 with an shRNA-
resistant version of LRRTM2 (DKD-LRR2) (Ko et al., 2011;
Soler-Llavina et al., 2011). (We did not attempt rescue experi-
ments with LRRTM1 because overexpressed recombinant
LRRTM1 accumulates in the endoplasmic reticulum and traffics
poorly to the plasma membrane; Francks et al., 2007; Linhoff
et al., 2009.) LTP was rescued by expression of shRNA-resistant
LRRTM2 along with the shRNAs (Figures 2A and 2B; control =
1.57 ± 0.19, n = 10; DKD-LRR2 = 1.55 ± 0.15, n = 14). To interpret
such rescue experiments, it is important to determine whether
overexpression of the protein of interest alone has any measur-
able phenotype. Thus, we overexpressed LRRTM2 (LRR2OE;
Figure 2C) and found no effect on LTP when compared to
interleaved control neurons (Figure 2D; control = 1.79 ± 0.20,
n = 9; LRR2OE = 1.79 ± 0.18, n = 10). These results indicatethat the block of LTP caused by the LRRTM DKD is specific to
the loss of LRRTM1 and LRRTM2.
TheExtracellular Domain of LRRTMs Is Required for LTP
When LRRTMs are overexpressed, their extracellular domains
are necessary and sufficient for their ability to promote synapto-
genesis both in nonneuronal cells and cultured neurons (de Wit
et al., 2009; Linhoff et al., 2009). Moreover, LRRTM2, via its
extracellular domain, coimmunoprecipitates with the AMPAR
subunits GluA1 and GluA2 in an in vitro overexpression system
(de Wit et al., 2009). To determine the domain of LRRTMs that
is important for LTP, we expressed the extracellular domain of
LRRTM2 (fused to the transmembrane domain of the platelet-
derived growth factor receptor; Figure 2E; DKD-LRR2Ex)
(Ko et al., 2011; Soler-Llavina et al., 2011). Replacement of
endogenous LRRTMs with LRR2Ex resulted in LTP that was
comparable to the LTP measured in interleaved control cells
from the same sets of slices (Figure 2F; control = 1.57 ± 0.19,
n = 10 cells; DKD-LRR2Ex = 1.39 ± 0.14, n = 15 cells).
The extracellular domain of LRRTMs binds Nrxs with high
affinity (de Wit et al., 2009; Ko et al., 2009; Siddiqui et al.,
2010), an interaction that may be necessary for axons to make
synaptic contacts onto nonneuronal cells expressing LRRTM2Neuron 79, 439–446, August 7, 2013 ª2013 Elsevier Inc. 441
Figure 3. LRRTM1 and LRRTM2 DKD Prevents cLTP and Alters
Surface GluA1 Expression in Cultured Neurons
(A) Representative images from hippocampal neuronal cultures infected with
lentiviruses expressing the indicated constructs and immunostained for the
AMPAR subunit GluA1 20 min after treatment with control (cLTP) or glycine-
containing solution (+cLTP). (B) Summary graph showing surface GluA1 levels
in the three sets of cultures in basal conditions (cLTP) and after cLTP (+cLTP).
Bars represent mean ± SEM, p < 0.0001. (C) Representative images of
dendrites from cultured neurons infected with lentiviruses expressing the
indicated constructs and immunostained for GFP, GluA1, and vGluT1 in basal
conditions and after cLTP. (D–F) Summary quantification of the percentage of
GluA1 puncta that are synaptic (D) and the intensity of synaptic (E) and total (F)
GluA1 puncta in basal conditions and after cLTP. *p < 0.001. (G) Schematic of
the outside-out voltage-clamp configuration and fast glutamate perfusion
set-up. p, perfusion pipette; R, recording pipette; Con, control solution (ACSF);
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442 Neuron 79, 439–446, August 7, 2013 ª2013 Elsevier Inc.(Ko et al., 2011; Siddiqui et al., 2010). To test whether LRRTM
function in LTP requires binding to Nrxs, we introduced two
mutations (D260A, T262A) reported to prevent LRRTM-Nrx
interaction (Siddiqui et al., 2010) into the LRR2Ex replacement
construct (Figure 2G; DKD-LRR2ExAA). Cells expressing DKD-
LRR2ExAA exhibited dramatically reduced LTP relative to inter-
leaved controls (Figure 2H; control = 1.77 ± 0.16, n = 14 cells;
DKD-LRR2ExAA = 1.12 ± 0.14, n = 21 cells). Importantly, the
overexpressed LRR2ExAA reached the neuronal cell surface
and colocalized with the vesicular glutamate transporter vGluT1
(Figures S1 and S2 available online), suggesting that the muta-
tions in LRR2ExAA do not completely block LRRTM2 delivery
to the plasma membrane and its synaptic localization. The lack
of LTP rescue by LRR2ExAA could also be due to disruption of
the binding of LRRTM2 to AMPARs. To test this possibility, we
coexpressed FLAG-tagged GluA1 with mVenus-tagged, full-
length LRRTM2 or LRRTM2AA in HEK293T cells and examined
their interaction by immunoprecipitation (Figure S3). GluA1-
FLAG coimmunoprecipitated equally well with both wild-type
LRRTM2 and mutant LRRTM2AA, suggesting that the mutations
do not disrupt the association between LRRTM2 and GluA1.
These results demonstrate a critical role for the extracellular
LRR domain of LRRTMs, likely due to its interaction with Nrxs,
in LTP.
LRRTMs Stabilize Synaptic AMPARs in Cultured
Neurons
Changes in synaptic responses in slices do not necessarily
directly reflect changes in endogenous surface AMPARs. There-
fore, to test the role of LRRTM1 and LRRTM2 in NMDAR-trig-
gered delivery of endogenous AMPARs to the cell surface, we
used a neuronal culture model of LTP in which activation of
NMDARs leads to an increase in surface AMPARs at synapses
(termed cLTP for chemical LTP) (Ahmad et al., 2012; Jurado
et al., 2013; Lu et al., 2001; Park et al., 2004; Passafaro et al.,
2001). We infected cultured hippocampal neurons at 8 days
in vitro (DIV 8) with control (GFP alone), DKD, or DKD-LRR2
lentiviruses. At DIV 16–18, we briefly (3 min) incubated these
neurons with a control or cLTP solution. After 20 min, neurons
were fixed, immunostained for surface AMPARs containing
GluA1, and imaged with confocal microscopy (Figure 3A) (Ah-
mad et al., 2012; Jurado et al., 2013; Supplemental Experimental
Procedures). In control cells, the cLTP solution caused a clear
increase in total surface expression of AMPARs (Figures 3A
and 3B; control = 100% ± 7.0%, n = 41; control + cLTP =
194.5% ± 13.1%, n = 39). LRRTM DKD in cultured neurons
produced two major effects: an increase in basal surface levels
of AMPARs and a significant reduction in surface AMPARs after
cLTP (Figures 3A and 3B; DKD = 169.6%± 25.3%, n = 45; DKD +
cLTP = 110.9% ± 16.5%, n = 45). Both phenotypes wereGlu, ACSF + glutamate, AP-5, and cyclothiazide. (H) Representative gluta-
mate-evoked currents obtained from control and DKD patches (left) and
summary quantification (right) of currents. (I) Quantification of surface GluA1
levels in neurons expressing GFP, DKD, and DKD-LRR2 in basal conditions
and after cLTP induction. An increase in surface GluA1 levels can be detected
in DKD neurons 10 but not 20min after cLTP induction. (J) Quantification of the
change in relative GluA1 surface levels after cLTP at both time points. *p <
0.05. Summary data are presented as mean ± SEM. (See also Figures S4–S7.)
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and 3B; DKD-LRR2 = 102.1% ± 7.8%, n = 48; DKD-LRR2 +
cLTP = 184.6% ± 9.8%, n = 48). The increase in surface GluA1
caused by LRRTM DKD in basal conditions is unlikely due to
an upregulation of GluA1 expression since the total pool of
GluA1-containing AMPARs (surface + internal) was unaffected
(Figure S4).
The finding that LRRTMDKD increased basal levels of surface
AMPARs is difficult to reconcile with previous results reporting
that this same DKD in vivo in neonatal animals selectively
reduced AMPAR-mediated synaptic currents (Soler-Llavina
et al., 2011). Furthermore, LRRTM2 KD alone was reported to
decrease GluA1 puncta density in cultured hippocampal neu-
rons (de Wit et al., 2009), although the specificity of the shRNA
used in this study has been questioned (Ko et al., 2011). A
hypothesis that can reconcile these results and also account
for the block of LTP by LRRTM DKD is that LRRTMs contribute
to the stabilization of AMPARs at synapses and their absence
results in an accumulation of extrasynaptic AMPARs, perhaps
at the expense of synaptic ones. To test these hypotheses, we
quantified the relative levels of synaptic surface AMPARs,
defined as GluA1 puncta that colocalized with vGluT1. Under
basal conditions, LRRTMDKD caused a decrease in the propor-
tion of GluA1 puncta found at synapses (Figure 3D; control =
83.6% ± 2.14%, n = 20; DKD = 55.12 ± 3.85, n = 21) as well as
a decrease in the average intensity of GluA1 staining at synaptic
puncta (Figure 3E; control = 9.5 ± 1.16, n = 20; DKD = 6.0 ± 0.68,
n = 21). Consistent with the increase in total surface GluA1
caused by LRRTM DKD (Figure 3B), this manipulation caused
an increase in average puncta intensity when both synaptic
and extrasynaptic puncta were included (Figure 3F; control =
7.6 ± 1.62, n = 20; DKD = 16.9 ± 2.10, n = 21). Inducing cLTP
increased synaptic and total GluA1 puncta intensity in control
cells while causing a decrease in total, but not synaptic, GluA1
intensity in LRRTMDKD cells (Figures 3E and 3F; control: synap-
tic = 16.2 ± 1.42; total = 16.4 ± 1.80; DKD: 16.9 ± 2.10, n = 22;
DKD: synaptic = 6.8 ± 0.63; total = 9.4 ± 1.5; n = 21). All of
these measurements returned to control values when shRNA-
resistant LRRTM2 was also expressed (Figures 3C–3F; synaptic
GluA1: basal = 86.0% ± 1.27%, +cLTP = 88.8% ± 1.58%;
synaptic intensity = 9.7 ± 1.34, +cLTP = 18.9 ± 1.74; total
intensity = 7.5 ± 0.99, +cLTP = 15.4 ± 1.33; n = 24). These results
are consistent with the hypothesis that LRRTMs are required
to maintain a population of AMPARs at synapses and that
their reduction results in a concomitant decrease of synaptic
and increase in extrasynaptic AMPARs.
To further test whether LRRTM DKD causes an increase in
the levels of extrasynaptic surface AMPARs, we measured
AMPAR-mediated currents evoked by fast glutamate application
in somatic, outside-out patches (Figure 3G) obtained from
cultured neurons expressing either GFP alone or the LRRTM
shRNAs. The current amplitude measured in patches from
LRRTM DKD neurons was significantly larger than in control
patches (Figure 3H; control = 197.8 ± 23.9 pA, n = 23; DKD =
301 ± 36.4 pA, n = 25). These data provide an independent mea-
sure supporting the conclusion that LRRTM1 and LRRTM2 DKD
results in an increase in the levels of extrasynaptic surface
AMPARs.The hypothesis that LRRTMs are required for maintaining
recently delivered AMPARs at synapses during LTP predicts
that initial delivery of AMPARs to the plasma membrane shortly
after LTP induction should not be impaired. To test this predic-
tion, we examined surface GluA1 at two different time points
after cLTP induction in control, DKD, and DKD-LRR2 cultured
neurons (Figures 3I, 3J, and S5). At 10 min, there was a compa-
rable increase in surface GluA1 expression in all experimental
groups despite the fact that the LRRTM DKD again caused an
increase in basal surface levels of GluA1 (Figure 3I, 3J, and S5;
control, 100% ± 16.2%, n = 21; control + cLTP, 191.3% ±
21.2%, n = 26; DKD, 150.0% ± 14.5%, n = 26; DKD + cLTP,
214.2 ± 27.8, n = 20; DKD-LRR2, 101% ± 12.0%, n = 25; DKD-
LRR2 + cLTP, 164.8% ± 28.0%, n = 25). Importantly, at this
10 min time point in all groups, a clear increase in surface
GluA1 level at synapses was detected (Figure S6). Finally,
consistent with our previous experiments (Figures 3A–3D),
in these same sets of cultures 20 min after cLTP induction,
surface GluA1 expression was decreased by the LRRTM DKD,
whereas it was increased in both control and DKD-LRR2
neurons (Figures 3I and 3J; control, 100% ± 19.7%; control +
cLTP, 239.2% ± 32.7%; DKD, 168.7% ± 16.1%; DKD + cLTP,
114.2% ± 22.3%; DKD-LRR2, 98.5% ± 17.6%, DKD-LRR2 +
cLTP, 166.3 ± 26.7; n = 20–26 for each condition).
These results demonstrate that LRRTM DKD does not impair
the initial delivery of AMPARs to the plasma membrane and
synapses soon after cLTP induction and that the block of LTP
at later time points is due to the lack of retention of newly
delivered AMPARs to synapses. The decrease in total, but not
synaptic, surface GluA1 after glycine treatment in the DKD cells
suggests that the extrasynaptic AMPARs in the DKD cells may
be relatively unstable and more susceptible to endocytosis.
Consistent with this hypothesis, the constitutive endocytosis
of GluA1-containing AMPARs increased after LRRTM DKD and
returned to basal levels with expression of LRRTM2 (Figure S7).
LRRTMs Are Required for LTP at Mature Synapses
Our results suggest that LRRTMs are required for LTP at synap-
ses on early postnatal CA1 pyramidal neurons in vivo and on
cultured neurons in vitro. However, the effects of LRRTM DKD
on basal AMPAR-mediated synaptic responses in vivo depend
on the maturational state of the synapses (Soler-Llavina et al.,
2011). Furthermore, NL1 KD was reported to impair LTP at early
postnatal but not at mature synapses on CA1 pyramidal neurons
(Shipman and Nicoll, 2012), although the NL1 KO does not cause
a major impairment in LTP (Blundell et al., 2010), suggesting that
NL1 is not required during development to render synapses
competent for LTP. These findings raise the possibility that
LRRTMs may not play a critical role in mediating LTP at mature
synapses but instead that the in vivo LRRTM DKD at P0 may
prevent synapses from reaching a maturational state necessary
to support LTP. To address this possibility, we injected the
LRRTM DKD lentivirus into the CA1 region of P21 mice, a time
point at which synapses have largely matured, and then per-
formed recordings in slices prepared 14–18 days later (Figures
4A and 4B). P35–P39 control neurons expressed robust LTP
(Figure 4C), whereas LTP was dramatically reduced in DKD
neurons (Figures 4D and 4E; control = 2.1 ± 0.18, n = 13 cells;Neuron 79, 439–446, August 7, 2013 ª2013 Elsevier Inc. 443
Figure 4. In Vivo LRRTMDKD Impairs LTP in
Young Adult Hippocampus
(A) Diagram showing a mouse on stereotaxic
apparatus for injection of lentiviruses at P21. (B)
High-magnification (603) images of CA1 pyrami-
dal neurons in acute hippocampal slice in DIC (left)
and epifluorescence (right) modes showing a
patch pipette on an infected neuron from which a
whole recording was obtained. (C, D, F, and H)
Representative EPSCs (left) and time courses
(right) of LTP experiments obtained from a control
neuron (C) and neurons infected with DKD (D),
DKD-LRR2 (F), and DKD-LRR2Ex (H) lentiviruses,
respectively. (E, G, and I) Summary time course
(left), cumulative fraction of all experiments in the
set (middle), and quantification of the LTP magni-
tude (right) for neurons expressing the indicated
constructs and the corresponding controls. The
DKD and DKD-LRR2manipulations (D and F) were
performed in parallel and share the same group of
control neurons. For clarity and to facilitate visual
comparison, these control data are plotted in both
(E) and (G). *p < 0.001. Summary data are pre-
sented as mean ± SEM.
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LRRTMs Are Essential for LTPDKD = 1.26 ± 0.11, n = 12 cells). Furthermore, expression of
LRRTM2 rescued LTP (Figures 4F and 4G; DKD-LRR2 = 2.0 ±
0.30, n = 7 cells) as did expression of LRR2Ex (Figures 4H and
4I; control = 2.14 ± 0.41, n = 5 cells; DKD-LRR2Ex = 2.08 ±
0.33, n = 6 cells).
DISCUSSION
Despite decades of effort, the molecular mechanisms underlying
classic NMDAR-dependent LTP at excitatory synapses on hip-
pocampal CA1 pyramidal neurons remain poorly understood.
Indeed, recent work points out the need to re-examine current
hypotheses about LTP mechanisms (Granger et al., 2013; Lee
et al., 2013; Volk et al., 2013) and the importance of testing the
role of novel proteins. Here we investigated the role of LRRTMs
(Laure´n et al., 2003; Linhoff et al., 2009) in standard LTP
because, like NLs, LRRTMs form an adhesion complex with
Nrxs (de Wit et al., 2009; Ko et al., 2009, 2011; Siddiqui et al.,
2010), their in vivo KD during early postnatal development
affects AMPAR-mediated, but not NMDAR-mediated, synaptic
responses (Soler-Llavina et al., 2011), and they may directly
bind to AMPAR subunits (de Wit et al., 2009; Schwenk et al.,
2012). We find that LRRTM1 and LRRTM2 DKD in vivo blocks
LTP in neonatal CA1 pyramidal neurons, a deficit that is rescued
by wild-type LRRTM2. Further replacement experiments
revealed that the extracellular, but not intracellular, domain of
LRRTM2 is required for LTP. LTP was not rescued by expression
of a mutant LRRTM2 reported to impair binding to Nrxs (Siddiqui
et al., 2010), although whether this mutant quantitatively reaches
the surface to the same degree as wild-type LRRTM2 is
unknown. Importantly, LRRTM1 and LRRTM2 DKD in adult
CA1 pyramidal neurons in vivo also strongly impaired LTP. These444 Neuron 79, 439–446, August 7, 2013 ª2013 Elsevier Inc.results demonstrate that the block of LTP by LRRTM1 and
LRRTM2 DKD is not due to some unknown effect on synapse
maturation but rather to a critical role of LRRTMs in LTP at
mature synapses.
A cell culture model of LTP provided further insight into the
mechanisms by which LRRTMs may function in LTP. LRRTM1
and LRRTM2 DKD blocked this model of LTP and surprisingly
increased the net surface expression of AMPARs under basal
conditions. Immunocytochemical and electrophysiological
assays revealed that DKD caused an increase in surface ex-
pression of extrasynaptic AMPARs while decreasing synaptic
AMPARs. Furthermore, the DKD did not affect the initial increase
in surface and synaptic AMPAR expression 10 min after cLTP
induction yet caused a decrease in net AMPAR surface expres-
sion when measured 20 min after cLTP. All of the effects of the
DKD in cultured neurons were reversed by wild-type LRRTM2,
suggesting that the phenotypes were not due to off-target
effects.
The results in cultured neurons are consistent with the
decrease in AMPAR-mediated synaptic transmission caused
by LRRTM DKD in vivo in neonatal hippocampus (de Wit et al.,
2009; Soler-Llavina et al., 2011) as well as the time course of
the block of LTP in acute slices. They support the hypothesis
that LRRTMs are required for maintaining a normal complement
of synaptic AMPARs to support basal synaptic transmission
but not for the AMPAR exocytosis that occurs after LTP induc-
tion. However, in adult CA1 pyramidal neurons, LRRTM1 and
LRRTM2 DKD did not have a detectable effect on basal
AMPAR-mediated synaptic transmission (Soler-Llavina et al.,
2011). A simple hypothesis to explain all of these results is that
in young, developing synapses LRRTMs serve two functions.
They help maintain a normal complement of synaptic AMPARs
Neuron
LRRTMs Are Essential for LTPfor basal synaptic transmission and, after LTP induction, they
contribute to the scaffolding or ‘‘slot’’ complex that stabilizes
the newly delivered AMPARs (Malinow and Malenka, 2002;
Opazo and Choquet, 2011). In their absence after LTP induction,
AMPARs transiently diffuse into but cannot be maintained within
the PSD; they escape to sites at which endocytosis occurs, a
process that may have been accelerated by the LTP induction
protocol. Indeed, while the LTP induction protocol in slices rarely
elicited LTD in control cells, it often elicited LTD in cells in which
LRRTM1 and LRRTM2 were knocked down or replaced with the
mutant LRR2ExAA (see cumulative fraction graphs in Figures 1E
and 2H). The lack of effect of LRRTM DKD on basal synaptic
transmission in adult CA1 pyramidal neurons (Soler-Llavina
et al., 2011) suggests that at mature synapses, LRRTMs either
do not play a role in maintaining a complement of AMPARs
to support basal synaptic transmission or that other molecules
can compensate for their loss. Nonetheless, our results support
the hypothesis that LRRTMs are required for stabilizing newly
delivered AMPARs during at least the first 40–50 min of LTP in
both developing and mature synapses.
The detailed molecular interactions by which LRRTMs may
stabilize AMPARs at synapses during LTP are unknown.
LRRTMs can directly interact with AMPAR subunits (de Wit
et al., 2009; Schwenk et al., 2012), and recent work supports
the hypothesis that binding of LRRTMs to presynaptic Nrxs is
critical for their maintenance, and perhaps function, at synapses
(Aoto et al., 2013). Specifically, constitutive genetic inclusion of
splice site 4 in Nrx3, which prevents Nrx binding to LRRTMs
(Ko et al., 2009), resulted in decreases in basal AMPAR synaptic
content, a block of LTP, an enhancement of constitutive
AMPAR endocytosis, and an 45% decrease in surface
levels of LRRTM2 (Aoto et al., 2013). Thus, the synaptic deficits
caused by inclusion of splice site 4 in Nrx3 are remarkably
similar to those caused by LRRTM DKD, suggesting that a
critical trans-synaptic protein complex required for maintaining
AMPARs at synapses may involve presynaptic Nrx interactions
with postsynaptic LRRTMs.
EXPERIMENTAL PROCEDURES
Detailed experimental procedures can be found in Supplemental Experimental
Procedures online.
SUPPLEMENTAL INFORMATION
Supplemental Information includes seven figures and Supplemental Experi-
mental Procedures and can be found with this article online at http://dx.doi.
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